0001209191-23-043531.txt : 20230727 0001209191-23-043531.hdr.sgml : 20230727 20230727162705 ACCESSION NUMBER: 0001209191-23-043531 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230725 FILED AS OF DATE: 20230727 DATE AS OF CHANGE: 20230727 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Randolph Sophia CENTRAL INDEX KEY: 0001817127 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39386 FILM NUMBER: 231118836 MAIL ADDRESS: STREET 1: C/O ALX ONCOLOGY HOLDINGS INC. STREET 2: 866 MALCOLM ROAD, SUITE 100 CITY: BURLINGAME STATE: CA ZIP: 94010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALX ONCOLOGY HOLDINGS INC CENTRAL INDEX KEY: 0001810182 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 850642577 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 323 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-466-7125 MAIL ADDRESS: STREET 1: 323 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0508 4 2023-07-25 0 0001810182 ALX ONCOLOGY HOLDINGS INC ALXO 0001817127 Randolph Sophia C/O ALX ONCOLOGY HOLDINGS INC. 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 1 1 0 0 Chief Medical Officer 0 Common Stock 2023-07-25 4 A 0 34000 A 315477 D Common Stock 5.86 2023-07-25 4 A 0 107000 0.00 A 2033-07-24 Common Stock 107000 107000 D The reported shares are represented by restricted stock units, or RSUs, which vest in eight equal semiannual installments beginning on December 28, 2023. Shares subject to the option vest in 48 equal monthly installments beginning on August 3, 2023. /s/ Peter Garcia, by power of attorney 2023-07-27